Cognitive Function in Patients With Persisted Atrial Fibrillation
SMART-AF
The Best Treatment Strategy for the Reservation of Cognitive Function in Patients With Persisted Atrial Fibrillation
1 other identifier
interventional
9
1 country
1
Brief Summary
Compare the difference of cognitive function between different treatment strategy in patients with persistent atrial fibrillation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2020
CompletedFirst Posted
Study publicly available on registry
August 11, 2020
CompletedStudy Start
First participant enrolled
November 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 26, 2025
CompletedJanuary 16, 2026
January 1, 2026
3.3 years
August 9, 2020
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive function
MOCA questionnaire
12 months
Cognitive function
brain MRI
12 months
Secondary Outcomes (3)
Quality of Life questionnaire
12 months
Hospitalization for cardiovascular cause
12 months
all cause mortality
12 months
Study Arms (2)
Rhythm control
EXPERIMENTALRhythm control with medication or any procedure
Rate control
ACTIVE COMPARATORRate control with medication or any procedure
Interventions
Eligibility Criteria
You may qualify if:
- Those who meet the diagnosis of persistent atrial fibrillation, meet one of the following conditions:
- The twelve-lead electrocardiogram is used to diagnose atrial fibrillation, and to cooperate with clinical diagnosis.
- hours ECG diagnosis 100% atrial fibrillation, with clinical diagnosis.
- The seven-day ECG recorder diagnosed 100% atrial fibrillation.
- Willing to accept treatment recommended by doctors, containing anticoagulant, and cooperate with examination and treatment in the coming year.
You may not qualify if:
- Unwilling to sign the clinical trial consent form.
- Unable to complete the cognitive function questionnaire.
- Unable to complete brain MRI examination due to various reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2020
First Posted
August 11, 2020
Study Start
November 30, 2020
Primary Completion
March 8, 2024
Study Completion
February 26, 2025
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share